![]() | Only 14 pages are availabe for public view |
Abstract Diffuse parenchymal lung diseases (DPLD) represent approximately 15% of consultations for the general pulmonologist.While a broad spectrum of DPLD exists, approximately 30% of these patients have idiopathic pulmonary fibrosis (IPF), a progressive fibrotic disease with variable clinical course but, in general, poor survival. The current approach to the diagnosis and management of DPLD includes a multidisciplinary discussion (MDD) undertaken by clinicians,radiologists, and pathologists. |